FDA to Hold First Public Hearing on CBD This Month
It’s a slow process, but the Food and Drug Administration is inching toward a new policy that would allow CBD products in food and beverages.
The agency will hold its first meeting on the matter at the end of the month. The purpose of the public hearing is “to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds” per an agency announcement. It is being held at the FDA White Oak Campus in Silver Spring, Maryland from 8 a.m. to 6 p.m. on May 31, with results expected by summer.
"It's critical that we address these unanswered questions about CBD and other cannabis and cannabis-derived products to help inform the FDA's regulatory oversight of these products — especially as the agency considers whether it could be appropriate to exercise its authority to allow the use of CBD in dietary supplements and other foods," said outgoing FDA Commissioner Scott Gottlieb (CNBC).
As CalMarijuanaPolicy reported previously, Congress effectively legalized hemp-derived CBD in December. However, the FDA’s prohibition on CBD containing foods and drinks has continued and has prevented the products from proliferating fully.